{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:53:12Z","timestamp":1648770792686},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0118938","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T19:38:13Z","timestamp":1426880293000},"page":"e0118938","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytology and Human Papillomavirus Co-Test Results Preceding Incident High-Grade Cervical Intraepithelial Neoplasia"],"prefix":"10.1371","volume":"10","author":[{"given":"Ina U.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Wojtal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo B.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Michele","family":"Manos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ypmed.2007.06.007","article-title":"Process of care failures in invasive cervical cancer: systematic review and meta-analysis","volume":"45","author":"AR Spence","year":"2007","journal-title":"Prev Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/GRF.0b013e31804a8285","article-title":"Cervical cancer screening in the 21st century: is it time to retire the Pap smear?","volume":"50","author":"TC Wright Jr","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"M Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.281.17.1605","article-title":"Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results","volume":"281","author":"MM Manos","year":"1999","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"D Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref6","unstructured":"United States Food and Drug Administration. Digene Hybrid Capture 2 High-Risk HPV DNA Test\u2014P890064 S009 A004. 2003; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/DeviceApprovalsandClearances\/Recently-ApprovedDevices\/ucm082556.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/DeviceApprovalsandClearances\/Recently-ApprovedDevices\/ucm082556.htm<\/ext-link>. Accessed 5 September 2014."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"HA Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"DC Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"MJ Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"D Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"L Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"ref12","first-page":"973","article-title":"Where&apos;s the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses","volume":"91","author":"WK Kinney","year":"1998","journal-title":"Obstet Gynecol"},{"key":"ref13","unstructured":"Kaiser Permanente. Fast Facts About Kaiser Permanente.; Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/xnet.kp.org\/newscenter\/aboutkp\/fastfacts.html\" xlink:type=\"simple\">http:\/\/xnet.kp.org\/newscenter\/aboutkp\/fastfacts.html<\/ext-link>. Accessed 05\/21\/2011."},{"key":"ref14","article-title":"How Does the Adult Kaiser Permanente Membership in Northern California Compare with the Larger Community?","author":"NP Gordon","year":"2006"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"TC Wright Jr","year":"2004","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"D Solomon","year":"2002","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"PE Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"LS Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"P Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"HC Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"J Cuzick","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"G Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"NW Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.5858\/arpa.2012-0307-OA","article-title":"Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2\/3","volume":"137","author":"C Zhao","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"M Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial","volume":"335","author":"G Ronco","year":"2007","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"AG Siebers","year":"2009","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the US Preventive Services Task Force","volume":"155","author":"EP Whitlock","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"SD Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"TC Wright Jr","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMp0911380","article-title":"Cervical-cancer screening\u2014new guidelines and the balance between benefits and harms","volume":"361","author":"GF Sawaya","year":"2009","journal-title":"N Engl J Med"},{"key":"ref32","unstructured":"United States Food and Drug Administration. (24 April 2014). FDA approves first human papillomavirus test for primary cervical cancer screening. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm394773.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm394773.htm<\/ext-link>. Accessed 9\/5\/2014."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0118938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:40:19Z","timestamp":1540345219000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0118938"}},"subtitle":[],"editor":[{"given":"Marcia Edilaine Lopes","family":"Consolaro","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0118938","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}